CD

Chiranjeeb Dey

Active Director Director DIN 11431120
DIN 11431120 First appointment Dec 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Chiranjeeb Dey

Data last updated:

Chiranjeeb Dey is a Director at Clarinth.Ai Private Limited (since 2025). The company operates in Healthcare.

DIN 11431120
Primary Designation Director
Industry Healthcare
First Appointment 16 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clarinth.Ai Private Limited U58200KA2025PTC212499
Director16 Dec 20252025Active

Board colleagues of Chiranjeeb Dey

NameDINCompanyDesignation
Subhojit Dasgupta11431119Clarinth.Ai Private LimitedDirector

Directorship timeline

Open interactive timeline →
Clarinth.Ai Private Limited
Premium access

Shareholding and investment profile for Chiranjeeb Dey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chiranjeeb Dey

Chiranjeeb Dey currently holds 1 directorship: Clarinth.Ai Private Limited (Director, since 16 Dec 2025).

Chiranjeeb Dey was first appointed on 16 Dec 2025 as Director at Clarinth.Ai Private Limited.

The current boards of Chiranjeeb Dey's companies include Subhojit Dasgupta (Clarinth.Ai Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available